Blog: Mass Tort Litigation
- Syngenta Is Ending Paraquat Production in 2026: What Pennsylvania Families Should Know About Paraquat Exposure and Parkinson’s Disease
Apr 21, 2026
For many people in Pennsylvania and across the country, paraquat is not just the name of a chemical. It is tied to difficult questions about past exposure, serious health concerns, and whether a Parkinson’s diagnosis may be connected to work or environmental conditions tied to agricultural or commercial herbicide use. Those concerns have only grown after Syngenta announced that it will cease global production of paraquat by the end of June 2026. The company has...Read More - Dupixent and CTCL: Can You File a Lawsuit After a Lymphoma Diagnosis?
Mar 19, 2026
If you or your loved one used Dupixent and later received a diagnosis of cutaneous T-cell lymphoma (CTCL), you may be dealing with far more than medical uncertainty. You may be facing mounting bills, a frightening cancer diagnosis, questions about whether warning signs were missed, and a growing fear that your medication may have contributed to your CTCL diagnosis a worsening condition. These are serious concerns, and they deserve clear answers and careful legal attention...Read More
